Eastern CT Hematology and Oncology Associates

Norwich, Connecticut 06360-2740

0 studies enrolling now · 11 studies all time

What they study most

Adenoma, Adult Solid Tumor, Advanced Non-Small Cell Lung Cancer, Advanced Unresectable or Metastatic Solid Malignancy, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Cancer, Carcinoma, Transitional Cell, Colon Cancer, Colon Diseases, Colon Lesion

Studies at this site

• A Study to Learn if a Combination of Fianlimab and Cemiplimab Versus Cemiplimab Alone is More Effective for Adult Participants With Advanced Non-Small Cell Lung Cancer (NSCLC) — Running, not enrolling
• Enfortumab Vedotin and Pembrolizumab vs. Chemotherapy Alone in Untreated Locally Advanced or Metastatic Urothelial Cancer — Running, not enrolling
• A Study of Enfortumab Vedotin Alone or With Other Therapies for Treatment of Urothelial Cancer — Stopped early
• Prevention of Colorectal Cancer Through Multiomics Blood Testing — Completed
• The Vallania Study: A Case Control Study for the Development of Multiomics Blood Tests for Cancer Screening — Completed
• A Study of Ladiratuzumab Vedotin in Advanced Solid Tumors — Stopped early
• A Study Evaluating Targeted Therapies in Participants Who Have Advanced Solid Tumors With Genomic Alterations or Protein Expression Patterns Predictive of Response — Completed
• Registrational Trial to Compare Effectiveness of Two Digital Software Medical Devices as Adjunctive Oncology Treatment — Stopped early
• CANscriptTM Clinical Outcomes in a Real-World Setting (ANCERS)-2 — Paused
• Safety and Pharmacokinetics Study of ODM-201 in Castrate Resistant Prostate Cancer — Completed
• Safety and Tolerability of ODM-201 in Castrate Resistant Prostate Cancer; Extension Study to Study 3104001 — Completed